Ignite Creation Date:
2024-05-06 @ 12:19 AM
Last Modification Date:
2024-10-26 @ 10:48 AM
Study NCT ID:
NCT01543932
Status:
COMPLETED
Last Update Posted:
2013-12-11
First Post:
2012-02-21
Brief Title:
High Clopidogrel Dose Versus Prasugrel and Ticagrelor in High Reactive Stable Patients
Sponsor:
University of Roma La Sapienza
Organization:
University of Roma La Sapienza
Study Overview
Official Title:
Comparison of Therapy With TICAGRELOR Prasugrel and High Clopidogrel Dose in PCI Patients With High on Treatment Platelet Reactivity and Genotype Variation
Status:
COMPLETED
Status Verified Date:
2013-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
TRIPLETE RESET
Brief Summary:
Dual antiplatelet therapy with Aspirin and Clopidogrel for at least one year is essential in patients following an acute coronary syndrome ACS or percutaneous coronary intervention PCI with drug eluting stents implantation Interindividual variability in platelet response to Clopidogrel has been reported with several mechanisms intrinsic high platelet reactivity PR variability of the drug metabolism and various drug interactions being implicated for high post-Clopidogrel treatment PR The investigators aim to perform a prospective single-center investigator-initiated randomized study to compare platelet inhibition by Prasugrel 10 mgday Ticagrelor 90 mg twice daily and high-dose 150 mgday Clopidogrel in patients with High on-treatment platelet reactivity HTPR with standard dose of Clopidogrel Patients with HTPR defined as area under curve-AUC 450 or 45 Unit and with loss-of-function allele CYP2C192 will be enrolled in the study and will be randomized Day 0 in a 111 ratio to either Clopidogrel 150 mg a day or Prasugrel 10 mg a day or Ticagrelor 90 mg twice daily until Day-15 and-30 post randomization
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None